Hos nogle patienter var der reduktioner i trombocyttal og forhøjet chitotriosidaseaktivitet, hvilket tyder på, at Zavesca- monoterapi måske ikkeopretholder samme kontrol med sygdomsaktiviteten hos alle patienter.
In some patients there were reductions in platelet count and increases in chitotriosidase activity indicating that Zavesca monotherapy may not maintain the same control of disease activity in all patients.